ArticleFrontiers in immunology2026
Characterization of virus neuroinvasion, blood-brain barrier integrity and neuroinflammation following Powassan virus infection in mice.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Powassan virus (POWV) is a tick-borne Orthoflavivirus transmitted by Ixodes tick species. POWV causes fatal encephalitis in approximately 10-30% of neurological cases, and long-lasting neurological sequelae in approximately 50% of survivors. POWV entry into the central nervous system (CNS) is an important event in determining clinical outcome. In this study, we evaluated viral replication kinetics, neuropathology, as well as host immune response following POWV infection in C57BL/6J (WT) mice. Our data showed that infection with POWV by all inoculation routes, including the intravenous, intraperitoneal, intracranial and subcutaneous, led to severe neuroinvasive disease. We showed that POWV effectively replicates in WT mice, where replication and dissemination resulted in peripheral and neurotropic phases. Viral neuroinvasion correlated with severe neuropathological alterations as well as enhanced blood-brain barrier permeability. Next, we used transcriptomics to compare the induction of effector pathways in the brain during the acute and late stages of POWV infection in mice. At all examined time points, we found several dysregulated genes including genes associated with interferon signaling, neuroinflammation and cell death signaling. We detected significant increase in the protein levels of markers involved in neuroinflammation in POWV-infected brains. Immunofluorescence analyses further validated the transcriptomic findings and demonstrated increased activation of microglia (IBA1) and astrocytes (GFAP), infiltration of peripheral immune cells (CD45), and elevated neuronal cell death (TUNEL) in POWV-infected brains. Increased protein expression of caspase-3 and p16 further indicated activation of apoptotic and senescence-associated pathways. Interestingly, we detected viral RNA and found evidence of neuroinflammation persistence, albeit at lower levels, in mice that survived the acute POWV encephalitis phase. Overall, this study provides a comprehensive understanding of the pathogenic events that occur during the acute and late stages of POWV infection in mice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.